GlitazOne Treatment for Coronavirus HypoxiA, a Safety and Tolerability Open Label With Matching Cohort Pilot Study
PHASE4CompletedINTERVENTIONAL
Enrollment
10
Participants
Timeline
Start Date
May 21, 2020
Primary Completion Date
November 1, 2020
Study Completion Date
December 1, 2020
Conditions
Coronavirus InfectionDiabetes
Interventions
DRUG
Pioglitazone
Receive pioglitazone 15mg - 30mg daily
Trial Locations (1)
97330
Good Samaritan Hospital Corvallis, Corvallis
All Listed Sponsors
lead
Samaritan Health Services
OTHER
NCT04473274 - GlitazOne Treatment for Coronavirus HypoxiA, a Safety and Tolerability Open Label With Matching Cohort Pilot Study | Biotech Hunter | Biotech Hunter